NADMED
Last verified 2026-06-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.8Mattributed |
|---|---|
| Latest round | series-a, $3.8M, 2024-08-01attributed |
| Founded | 2018 |
| Headquarters | Helsinki, Finland |
| Industry | healthtech |
| Stage | series-a |
| Website | nadmed.com |
Vitamin B3 deficiency testing
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-08-01 | series-a | $3.8M | undisclosed |
Detected tech stack
clicky, ewww image optimizer, fitvids.js 4.27.6, gravity forms 2.10.3, hsts, jquery 3.7.1, jquery migrate 3.4.1, jquery mobile, magnific popup 4.2.3, mysql, nginx, php
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $3.8M | attributed | eu-startups named as publisher. No document URL on file. |
| Total raised $3.8M | attributed | eu-startups named as publisher. No document URL on file. |
| Company existence | self-reported | nadmed.com, read 2026-06-02 |
| Description | self-reported | nadmed.com, read 2026-06-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.